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abstract: The scarce amount of DNA contained in a singe cell is a limiting factor for clinical application of preimplantation genetic
diagnosis mainly due to the risk of misdiagnosis caused by allele dropout and the difﬁculty in obtaining copy number variations in all
23 pairs of chromosomes. Multiple displacement ampliﬁcation (MDA) has been reported to generate large quantity of products from
small amount of templates. Here, we evaluated the ﬁdelity of whole-genome ampliﬁcation MDA from single or a few cells and determined
the accuracy of chromosome copy number assessment on these MDA products using an Affymetrix 10K 2.0 SNP Mapping Array. An average
coverage rate (86.2%) from single cells was obtained and the rates increased signiﬁcantly when ﬁve or more cells were used as templates.
Higher concordance for chromosome copy number from single cells could be achieved when the MDA ampliﬁed product was used as refer-
ence (93.1%) than when gDNA used as reference (82.8%). The present study indicates that satisfactory genome coverage can be obtained
from single-cell MDA which may be used for studies where only a minute amount of genetic materials is available. Clinically, MDA coupled
with SNP mapping array may provide a reliable and accurate method for chromosome copy number analysis and most likely for the detection
of single-gene disorders as well.
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Introduction
Accurate analysis from a minute amount of DNA has been a challenge
for geneticists. Several PCR-based protocols for whole-genome ampli-
ﬁcation (WGA) have been established and their applications evalu-
ated, including primer extension preampliﬁcation (PEP) (Zhang et al.,
1992; Xu et al., 1993) and degenerate oligonucleotide-primed PCR
(DOP-PCR) (Telenius et al., 1992; Wilton et al., 2001). However,
these protocols all have their limitations, including limited yield,
strong biases and/or low genome coverage deﬁned as gene represen-
tation (Cheung et al., 1996; Paunio et al., 1996; Kittler et al., 2002;
Coskun et al., 2007). In the past few years, a non-PCR-based WGA
called multiple displacement ampliﬁcation (MDA) has been introduced
(Dean et al., 2002). Taking advantage of the phi29 DNA polymerase,
an enzyme with higher processivity and better proofreading activity
compared with Taq DNA polymerase, MDA shows some unique
advantages over PCR-based WGA, including better ﬁdelity as it has:
an error rate of less than 3   10
26 (Nelson et al., 2002), compared
with 3   10
25 for Taq DNA polymerase; a higher average yield
from a single cell varying from 1.7 to over 35 mg (Handyside et al.,
2004; Jiang et al., 2005; Spits et al., 2006); larger ampliﬁed DNA frag-
ments (.10 kb); and more uniform representation of sequences
(Paez et al., 2004). For these reasons, MDA is now increasingly
used in many studies including preimplantation genetic diagnosis
(PGD) where molecular and cytogenetic diagnosis is based on the
analysis of one cell only, in majority of cases, or a few cells from
human embryos. Nevertheless, the scarce amount of DNA contained
in a single cell as templates still poses a challenge for wide use of PGD
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the loss of heterozygosity due to ampliﬁcation failure of one of the two
alleles. ADO rates of MDA products from single cells are reported to
be from 0 to 60% (Handyside et al., 2004; Hellani et al., 2004; Spits
et al., 2006; Ren et al., 2007; Renwick et al., 2007) and appear to
be affected by multiple factors when PCR is used to amplify single-cell
DNA (Piyamongkol et al., 2003). However, these studies are based on
the analysis of small number of markers (up to 64 polymorphic micro-
satellite markers) and on a limited number of chromosomes (seven
different chromosomes). A comprehensive proﬁle of MDA genome
coverage is not available.
Although different types of chromosomal abnormalities in all 23
pairs of chromosomes have been successfully detected by array-based
comparative genomic hybridization (aCGH) using MDA products from
single cells (Hellani et al., 2004; Le Caignec et al., 2006), several critical
issues need to be addressed before it can be safely used for clinical
PGD. First, the extent of over- and/or under-representations in the
ﬁnal MDA products is unclear and the accuracy of aCGH from
MDA products requires further evaluation (Paez et al., 2004; Le
Caignec et al., 2006). Second, aCGH has yet to be tested for detecting
copy number aberrations and single-gene disorders simultaneously.
And ﬁnally, the current aCGH protocol is a time-consuming process
that does not seem to ﬁt easily into all clinical PGD schedule, particu-
larly if specimens are required to be shipped to a reference laboratory,
though a promising report on this has been published recently (Hellani
et al., 2008). Looking for alternative platforms and potentials for the
detection of both chromosome copy number abnormalities and
single-gene disorders, the present study focuses on the analysis of ﬁde-
lity of MDA in terms of whole-genome analysis of ADO and the
genome coverage of MDA from single cells. This study, however,
does not focus on the detection of any single-gene disorders though
potentially feasible. Initially used for linkage analysis (Middleton
et al., 2004), an SNP mapping array can not only provide a reliable
method to evaluate DNA products on genotype, but is also a poten-
tial tool for the detection of chromosome copy number aberrations
with high accuracy and reproducibility. Our objective is, therefore,
to evaluate single-cell DNA ampliﬁed by MDA using SNP array,
which may overcome above-mentioned limitations of aCGH. In this
study, the Affymetrix 10 K 2.0 SNP mapping array was chosen
because this platform contained over 10 000 SNPs and was reported
to perform accurately for the analysis of small quantities of DNA (Paez
et al., 2004; Tzvetkov et al., 2005; Corneveaux et al., 2007).
Materials and Methods
MDA sample preparation
Two cell lines, a trisomy 18 (Tri-18; GM02 732, 47, XY,þ18) and a
chromosome 4 segment deletion [sDel-4; GM00 343, 46,XY,4(del)(qter.
p14)] from Coriell Cell Repositories/NIGMS (Camden, NJ), were chosen
for the study. Cells were collected as described before (Spits et al., 2006)
with minor modiﬁcations. Brieﬂy, prior to cell collection, cell cultures were
treated with 0.25% trypsin–EDTA and twice washed in PBS. Genomic
DNA was extracted from cells using QIAamp DNA Blood Mini Kit
(QIAGEN Sciences, MD). Different number of cells (1, 2, 5 and 10)
were picked up under a dissection microscope by a glass pipette and
placed into PCR tubes containing 5 ml alkaline lysis buffer (200 mM
KOH, 50 mM dithiothreitol) and the tubes were then stored at 2808C
before use. Aliquotes of 5 ml lysis buffer without cells were used as nega-
tive controls. Lysis was performed at 658C for 10 min followed by addition
of 5 ml neutralization buffer (400 mM Tricine). All necessary steps were
taken to avoid contamination during the whole procedure.
MDA and experimental groups
Whole-genome ampliﬁcation by phi29 polymerase-based MDA was per-
formed using REPLI-g Midi Kit (QIAGEN Sciences, MD) with a ﬁnal
volume of 50 ml. MDA reactions were carried out at 308C for 8 h and ter-
minated by incubation at 658C for 10 min. The products were puriﬁed
using QIAamp DNA Micro Kit (QIAGEN Sciences, MD), quantiﬁed
using ND-1000 spectrophotometer (NanoDrop Technologies,
Denmark) and then stored at 2208C before next step. Considering the
amount of specimens potentially available from clinical PGD, a total of
seven experimental groups, using cells or extracted DNA from Tri-18
cell line, were established for genotype analysis. These included MDA pro-
ducts from: (1) a negative control with no templates (Neg); (2) a single cell
(1C); (3) pooled from two separate single-cell MDA reactions (1 þ 1C);
(4) two cells (2C); (5) ﬁve cells (5C); (6) ten cells (10C); and (7) unampli-
ﬁed genomic DNA (gDNA). In a separate experiment, single cells were
obtained from the sDel-4 cell line and MDA was performed in the same
manner as in group 2 (1C-sDel-4). Three replicates were included in
each group; except group 2 (1C) and group 3 (1 þ 1C), both of which
had six replicates, respectively. Detailed numbers of array used for each
group are listed in Table I. For aneuploidy detection, a mean and standard
deviation (SD) of all log2 signal intensity ratios of each array (10 M smooth-
ing treatment by CNAT4.0) was calculated, and the array-speciﬁc
threshold to deﬁne euploidy was determined as the mean plus or minus
three times of the SD. The average log2 ratio of each chromosome on a
certain array was compared with this threshold and ratios exceeding the
threshold indicated aneuploidy or euploidy otherwise.
The MDA products were treated as previously described (Tzvetkov
et al., 2005). Brieﬂy, 250 ng of MDA products or unampliﬁed genomic
DNA was digested with XbaI, ligated to a universal adaptor and ampliﬁed
using primers complementary to the adaptor sequence. After puriﬁcation,
the products, which were less than 1 kb in sizes, were digested to the sizes
of about 50 bp with DNase I, end-labeled with biotin, and hybridized to
the mapping array for 16 h at 488C. The arrays were then washed and
stained with R-Phycoerythrin Streptavidin using the Fluidics Station 450
and scanned using the GeneChip Scanner 3000 from Affymetrix.
Genotyping and copy number analysis
The 10 K 2.0 SNP mapping arrays, containing over 10 000 SNPs, and assay
kits were purchased from Affymetrix along with 45 normal reference DNA
data sets from blood samples (Affymetrix, Santa Clara, CA). The probes
on this array were 25-mer each and the mean intermarker distance was
210 kb on 22 autosomes and the X chromosome. Data were analyzed
using GeneChip
w Genotyping Analysis Software (GCOS 1.2), GeneChip
w
Genotyping Analysis Software (GTYPE 4.1) and Copy Number Analysis
Tool (CNAT 4.0) from Affymetrix. The GC content of each SNP
segment was obtained from NetAffxTM Analysis Center of Affymetrix. A
window of 250 000 bases to each side of that SNP was used and the frac-
tion of bases that were G and C was calculated for each SNP in a chromo-
some. For coverage and ﬁdelity analysis, the call rate on the array was
deﬁned as the SNP that could be correctly read and the call rate was
used as the index of genome coverage in the study.
An algorithm called relative allele signal (RAS) was used for calculation
of genotype from the signals measured (Kennedy et al., 2003). Brieﬂy, the
genotype of a locus is determined by the ratio of allele A signal to the
sum of signals of A and B [A/(A þ B)], and RAS should be 0, 0.5 and 1
for BB, AB and AA, respectively. However, artifacts such as ADO, PA
740 Ling et al.(preferential ampliﬁcation, where one allele is over-ampliﬁed with respect
to the other, but both are above the threshold of detection) or LOH (loss
of heterozygosity) may occur. For MDA ﬁdelity analysis, it is critical to dis-
tinguish ADO and PA from LOH. Here we developed an analysis method
as followings. First, using the GCOS1.2 and GTYPE4.1, the SNP types
(AA, AB or BB) on each array were obtained. For each replicate, those
SNPs showing AA type in all unampliﬁed samples (Group gDNA) and
this replicate were picked up and the allele B signal intensity of these
SNPs in the replicate could be then calculated. The 95th percentile of
the allele B signal intensities was set as the threshold. The signal intensity
of each LOH SNP (AB!AA) in this replicate was compared with the
threshold. A locus was assigned as PA, or otherwise ADO, if the allele
B intensity of a locus with LOH was above the threshold. With the
same method we could differentiate ADO from PA of other LOH SNPs
(AB!BB). The assignment of PA and ADO was done on an individual
chip with the threshold for the chip and the false discovery rate (an
SNP was true ADO but misdiagnosed as PA) was restricted to below
5%. We applied this method to all chips to assign PA and ADO of the
locus to differentiate from LOH.
The copy number analysis tool from Affymetrix divides the results into
ﬁve categories: 0, 1, 2, 3, 4 or more. To evaluate how well the copy
number estimates were preserved after MDA from different number of
cells, we deﬁned the copy number zero and one as under-representation,
two as correct representation and three or more as over-representation.
For copy number analysis, two types of references were compared. First,
we used combined data from 25 unampliﬁed male samples provided by an
Affymetrix database. Second, we used the data from the MDA products
from single cells, either from Tri-18 or from sDel-4. When Tri-18 cells
were used as reference, copy number 1 for chromosome 18 was regarded
as correct representation. Likewise, a copy number 3 for the deleted
segment of chromosome 4 was regarded as correct representation
when sDel-4 cells were used as reference. Thus correct representation
could be regarded as copy number concordance after MDA.
Results
Yield and genome coverage of MDA
Following the MDA, the yield of double-stranded DNA in each group
was 19.3+1.0, 19.1+1.2, 19.6+0.6 and 20.9+1.4 mg, respect-
ively from 1C, 2C, 5C and 10C Tri-18 ﬁbroblasts; and MDA from
negative controls generated a similar amount of products (19.4+
1.5 mg). No signiﬁcant difference was found between any groups
(P . 0.05). The genome coverage following whole-genome ampliﬁca-
tion was estimated based on the call rate of each sample. The SNP call
rates from 1C, 1 þ 1C and 2C groups showed no signiﬁcant differ-
ences (86.2, 85.9 and 86.7%, respectively, P . 0.05). When the cell
numbers increased to 5–10 cells, however, the call rate presented a
signiﬁcant difference (90.4 and 96.3%, respectively P ¼ 0.02). An
extremely low call rate (5.3+1.2%) in the negative control group
was observed compared with the experimental groups indicating
that these products were non-speciﬁc and their impact on the SNP
signals was likely insigniﬁcant. The increase in the mean call rate
reﬂected random gain of genome coverage when cell numbers
increased in the template as most uncalled SNPs were not consistent
in different experimental groups (Fig. 1).
Compared with the mean number of uncalled SNPs in each group,
ranging from 375 to 1420, the number of consistent uncalled SNPs
was only about 10% (from 35 to 185) (Fig. 1a and b). To further inves-
tigate whether GC content inﬂuenced the occurrence of these uncalled
.
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Genome coverage and ﬁdelity of MDA from single cells 741SNPs, we compared the GC content of the segments from which these
consistent SNPs stood in each group to that of the overall SNPs on the
array. Only those consistent uncalled SNPs in a single-cell group (group
1C) showed a signiﬁcantly higher GC content (42.15% versus 39.86%,
P , 0.05), but no correlation of GC content related to uncalled SNPs
was seen in other groups (P . 0.05).
Fidelity of MDA for SNP analysis
Alleledropoutwasassessedineachgroup.OnlythoseSNPsgiving‘calls’
inbothunampliﬁedandreplicatepairswereincludedforfurtheranalysis.
Three SNP genotypes among MDA ampliﬁed and unampliﬁed groups
were deﬁned in this study: loss of heterozygosity (LOH, AB!AA or
BB), gain of heterozygosity (GOH, AA or BB!AB) and change of
homozygosity (COH, AA!BB or BB!AA). All these changes
(LOH, GOH and COH) decreased as the cell number increased. The
most dramatic difference was observed in the LOH type which
decreased signiﬁcantly with the increasing number of cells in the MDA
reaction (P , 0.05, respectively), whereas GOH was observed in
much smaller number of SNPs and only four SNPs were COH in four
replicates (three in group 1C and one in group 2C) (Fig. 2a). Similar to
LOH, the rates of ADO and PAdecreased dramatically with an increas-
ing numberof starting cells (Fig. 2b). ADO rates varied greatly in Group
1C (19.46+9.13%, with a range from 4.71 to 29.5%) and only a very
small number of consistent ADO and PA SNPs existed (from 0 to 2)
in eachgroup. Furthercomparison betweenthe GC content of the seg-
ments for which these consistent SNPs were located and those of the
overall SNPs on the array showed no correlation (P . 0.05).
Figure 1 Distribution analysis of uncalled SNPs along the genome. The comparison between each multiple displacement ampliﬁcation (MDA)
experimental groups and the gDNA group showed that more uncalled SNPs existed when less number of cells was used as templates. The mean
number of uncalled SNPs decreased when number of cells used as templates increased. Most of uncalled SNPs appeared to be not consistent, indi-
cating a random loss of genome coverage. (a) Mean number of uncalled SNPs. The group 1C, 1 þ 1C and 2C showed similar mean number of
uncalled SNPs. A very small number of uncalled SNPs could be seen in the gDNA group. (b) Number of consistent uncalled SNPs. The total
number of consistent uncalled SNPs was small in all groups, ranging from 35 to 185. Compared with that in group 1C (six replicates), the proportion
of the number of consistent uncalled SNPs to mean number of uncalled SNPs were higher in group 2C, 5C and 10C (three replicates). The smaller
sample size in these three groups might have contributed to this variation.
742 Ling et al.Detection of chromosomal abnormalities
from different number of cells
A total of 24 arrays were used for the chromosome copy number
detection (Table I). Concordance in chromosome copy number analy-
sis was signiﬁcantly higher when data from the single-cell MDA
product was used as reference than that when the gDNA data
were used as reference in group 1C and 1 þ 1C (P , 0.05), but not
in other groups (P ¼ 0.05) (Fig. 3). Although both the trisomy 18
and chromosome 4 segment deletion could be detected by this 10K
platform from a single cell, a few speciﬁc chromosomes showed a
higher tendency of PA than others, including chromosome 16, 17,
19 and 22, when gDNA data were used as reference (Fig. 4a).
PA disappeared, however, when data from the single-cell MDA
product were used as reference (Fig. 4b).
Discussion
MDA genome coverage
Compared with other PCR-based WGA methods, MDA is reported
to be a robust and less biased procedure for genome coverage
(Nelson et al., 2002; Handyside et al., 2004; Paez et al., 2004; Jiang
Figure 2 SNP genotype accuracy of MDA from different number of cells. (a) Impact of cell number on SNP genotype accuracy. Loss of hetero-
zygosity (LOH), but not gain of heterozygosity (GOH) nor change of homozygosity (COH), appeared to be affected signiﬁcantly by the number of cells
used as templates. Only those SNPs giving call in both MDA groups and gDNA group were included in the analysis and the mean number of SNPs of
each group was showed. LOH (AB!AA or BB); GOH (AA or BB!AB); COH (AA!BB or BB!AA). (b) Percentage of allele dropout (ADO) and
preferential ampliﬁcation (PA) of MDA products from different number of cells. Unlike the call rate, the ADO and PA rates decreased signiﬁcantly even
if the cell number increased from one to two cells or if two single-cell MDA products were pooled together (P , 0.05).
Genome coverage and ﬁdelity of MDA from single cells 743et al., 2005; Spits et al., 2006). No accurate and comprehensive
assessment of MDA products from single or a small number of cells
is yet available on its ﬁdelity, particularly, by high-resolution genetic
analysis. Though a previous study has shown that MDA could generate
a large amount of DNA product (Jiang et al., 2005), the nature of the
products has not been tested. Recently using SNP arrays a proﬁle of
MDA bias in single cells was reported (Iwamoto et al., 2007),
however, only one SNP for each chromosome was chosen to deﬁne
the allele threshold of ampliﬁcation in the study. Moreover, the knowl-
edge of unspeciﬁc products of MDA on the genotyping accuracy
(Handyside et al., 2004) is still limited. The present study conﬁrmed
the previous ﬁnding that a large quantity of DNA, close to 20 mg,
can be obtained from single cells after 8 h of MDA. The quantity of
DNA did not increase as more cells (up to 10) were included as tem-
plates. When high-density SNP arrays were used to assess the per-
formance of MDA from single cells and a small number of cells, we
found that the call rate, as an index of genome coverage, was very
low in the negative control group (5.3%), suggesting that these were
indeed non-speciﬁc products and would have a limited impact on
SNP signals. The call rate showed no differences between MDA ampli-
ﬁcation using 1C, 1 þ 1C or 2C (86.2, 85.9 and 86.7%, respectively,
P . 0.05). The genome coverage from a single cell in the present
study is lower than that reported by previous studies, which ranged
from 92 to 95% (Handyside et al., 2004; Hellani et al., 2004; Jiang
et al., 2005; Renwick et al., 2007). The difference could be due to
the fact that a limited number of markers (up to 64 SNPs on seven
chromosomes) were involved in estimating the genome coverage in
those studies whereas more than 10 000 SNPs were assessed in the
present study. Compared with the call rate of the one-cell group, sig-
niﬁcant differences were observed when 5 (90.4%) or 10 (96.3%) cells
were used (P ¼ 0.03 and 0.02). With the beneﬁt from the progression
of blastocyst cultivation in recent years, more cells can be removed
from an embryo (blastocyst biopsy). Our study showed that when
10 cells were used as the template, the call rate could be similar to
that of unampliﬁed DNA, indicating that a much more reliable result
could be achieved by blastocyst biopsy.
In our study, only a small number of SNPs (n ¼ 35) were not called
consistently in the one-cell group (Fig. 1b), suggesting a random and
not locus-speciﬁc failure of ampliﬁcation after MDA reaction from
single cells. Further analysis showed that the genomic regions where
these consistent uncalled SNPs located had a higher GC content
than the overall level through the array. This may be due to the
higher tendency for these GC rich regions to form secondary struc-
tures, which in turn may hamper the DNA synthesis from the tem-
plate during MDA. Although such a correlation could not be
observed in other groups (group 2C, 5C and 10C), the small
sample numbers in these groups (n ¼ 3 for each) might contribute
to the result. Further research with more samples is warranted.
SNP array for MDA ﬁdelity
If MDA is applied to PGD or other critical genetic analysis, the extent
of ADO must be evaluated. Handyside et al. (2004) reported an ADO
Figure 3 ComparisonbetweenSNPcopynumberconcordanceratesusingtwodifferentreferences.ThepercentagesaretheaverageproportionofSNPs
withconcordantcopynumberofeachgroup(seeMaterialsandMethods).Tomakethedatacomparablebetweendifferentgroups,theSNPslocatingonthe
chromosome18andchromosome4(betweenpterandp14)wereexcludedfromtheanalysis.Thecopynumberconcordancewassigniﬁcantlyhigheringroups
(*) 1C and 1 þ 1C groups when the single-cell MDA product was used as reference than when the normal DNA was used as reference (P , 0.05), but no
statistical difference could be observed in other groups (P ¼ 0.05). 1C-del: mDA product from a single cell of chromosome 4 segment deletion cell line.
744 Ling et al.rate of 31% on the analysis of 20 STRs with single-cell MDA. A similar
study suggested the ADO rate to be 10.25% for the b-globin gene and
5% for a total 16 STRs (Hellani et al., 2004). The variable ADO rates
observed may be due to the limited number of loci involved. A recent
study reported an ADO rate of 38.9% for MDA in single cells using an
SNP array (Iwamoto et al., 2007). To deﬁne whether or not the alleles
A and B were ampliﬁed, 23 SNPs (one from each autosome and X
chromosomes) were genotyped using a Taqman assay to set up the
threshold. Again, only one SNP was chosen for each chromosome.
The present study is the ﬁrst in which ADO from single-cell MDA pro-
ducts is estimated throughout the whole genome and thus represents
a more comprehensive assessment of ADO. In our study, a much
higher rate of LOH than that of GOH and COH was observed in
each group (Fig. 2a), suggesting that MDA rarely introduces new
alleles. Nevertheless, the possibilities that some calls in the exper-
imental groups may be due to the non-speciﬁc products cannot be
ruled out since the negative group also showed 5.3% call signals.
The ADO rates varied greatly from 4.71 to 29.5% among group the
one-cell group, which may be due to several reasons. Because only
one copy of template was involved, the state of the DNA might
have a great impact on the ﬁnal result. For example, the ADO rate
of replicate no. 3 in 1C group was much higher than those of other
replicates in the same group but close to the results of 2C group. It
is possible that the status of cell cycle may have contributed to the
variation. For example, if a cell that had just ﬁnished the DNA replica-
tion but not yet divided was picked up so that actually two copies of
DNA were present as templates. Furthermore, as ﬁbroblast cells lines
were cultured for number of passages, apoptosis or DNA fragmenta-
tion might have contributed to this variability. The overall ADO and
PA rates decreased dramatically from 17.9 and 18.2% with a single
cell to 0.1 and 0.05% with 10 cells (Fig. 2b), in agreement with a pre-
vious report (Handyside et al., 2004). It is important to emphasize that
the present study obtained a more comprehensive proﬁle for the
impact of cell number on the genotyping compared with a previous
study (Handyside et al., 2004) in which the ﬁdelity of MDA from
small numbers of cells was evaluated based on one locus as index only.
Interestingly, unlike the results of coverage analysis, in which the
pooled DNA from two single-cell (1 þ 1C) MDA reactions showed a
similar performance as that from two cells (Fig. 1b), the LOH rate of
the2Cgroupwasmuchlessthanthatof1 þ 1C(Fig.2a).Thismightindi-
cate that unspeciﬁc products were able to hybridize to the SNP array,
but they were not able to have the same impact on signal capture or
program analysis as the LOH rate is higher. In other words, slightly
higher LOH from the 1C group may have limited impact on accuracy.
The implication for clinical PGD is that biopsy of two cells may not
provide a huge advantage. Separate MDA reactions should be per-
formed when two single blastomeres are available, whereas pooled
twocellswouldberecommendedforMDAifLOHwastobeminimized.
Finally, when the SNP array is used for the detection of the ﬁdelity of
anyampliﬁcationmethods,weshouldnotregardLOHasADObecause
some allelic PAwill be easily mistaken as LOH by the RAS algorithm. As
our method has successfully been used to distinguish the ADO from
LOH in this 10K SNP mapping array, it can likely be extended to the
analysis of WGA products using other SNP mapping array platforms.
SNP array for copy number analysis
AsanalternativetoFISH,array-CGHhasbeensuccessfullyusedforchro-
mosomal imbalances detection in whole-genome ampliﬁed DNA
Figure 4 Comparison between copy number proﬁles using two different references. The single-cell MDA products of trisomy 18 and chromosome
4 segment deletion were used as reference to each other, so the copy number proﬁle showed a ‘fake’ trisomy 4 segment (black arrow in b) in trisomy
18 samples. (a) When the gDNA data were used as reference, some chromosomes (16, 17, 19, 20 and 22) presented obvious preferential ampliﬁca-
tion and made it difﬁcult to draw a conclusion. (b) Most preferential ampliﬁcation disappeared and trisomy 18 could be diagnosed (red arrow in b)
when data from a single-cell MDA product were used as reference.
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has been known, andwas demonstratedin the present study, that MDA
will introduce background noise in the absence of template DNA.
Whether these non-speciﬁcally ampliﬁed DNA will array randomly or
speciﬁcally hybridize to the array remains unclear (Paez et al., 2004; Le
Caignec et al., 2006). Controversy still exists regarding what sources of
reference should be used. Paez et al. (2004) suggested that an ampliﬁed
productusingthesamemethodshouldbeusedasreferencebecausethe
errorscausedbyMDAseemedtobesystematic.LeCaignecetal.(2006),
however, held a different view based on their ﬁndings on a BAC array to
detectthechromosomalimbalancefromsinglecells.Aftercomparingthe
copynumberconcordancebetweentheresultsusingthesetwodifferent
references,we found that ineachgroupthe mean copy numberconcor-
dance was much higher when the data from a single-cell MDA product
were used as reference (93.1% to 99.9%) than that from when normal
gDNAwas used asa reference (82.8–89.8%) (Fig. 3).A statisticaldiffer-
ence was observed in the 1C and 1 þ 1C groups (P , 0.05) but not in
others (P ¼ 0.05), most likely due to the small number of samples
involved in the present study.
Two explanations could be provided for this difference. First, unlike
what we found in the genotype analysis, most of the copy number
variations caused by MDA seem to be not randomly but systematically
distributed. From the copy number proﬁling (Fig. 4a and b), it
appeared that the PA was consistent in some speciﬁc chromosomes
(i.e. chromosome 16, 17, 19 and 22). This supports previous ﬁnding
that these chromosomes had poorer representation compared with
others (Paez et al., 2004). Although we could not ﬁnd any correlation
between GC content and PA on speciﬁc chromosomes as suggested
by others (Teo et al., 2008), the different gene density may explain
this phenomenon. We speculate that there are two types of chroma-
tin locating inside the interphase nuclei: a highly condensed form called
heterochromatin and a much less condensed form called euchromatin.
Most DNA that is folded into heterochromatin does not contain genes
(Alberts, 2002). Those chromosomes with higher gene density
(Renwick et al., 2007), such as chromosome 16, 17, 19 and 22, are
believed to have a higher proportion of euchromatin, whose loose
structure would allow more efﬁcient ampliﬁcation which might
produce some ‘artifacts’. Ampliﬁed controls from a similar low
amount of starting DNA may help to level up these errors and
increase the concordance rate. Second, as other oligonucleotide-CGH
platforms, an Affymetrix SNP mapping array cannot make a deﬁnite
call for a loss or gain for a speciﬁc SNP, signals of a few adjacent oli-
gonucleotides are required to be analyzed as a whole for a reliable call
(Ylstra et al., 2006). For this purpose, the Affymetrix copy number
analysis tool integrates the loci within a certain smoothing size as
one by the hidden Markov model, and one identical copy number
was given to all these loci in the ﬁnal result to reduce random
errors. All these may contribute to the high copy number concor-
dance when MDA ampliﬁed products were used as reference. More
rigorous comparison between the two types of references is required
before it can be used in clinical applications.
Here, in combination with MDA and an Affymetrix 10K 2.0 SNP
mapping array, we were able to successfully detect chromosomal
abnormalities such as trisomy and monosomy. Though this relatively
early version of an array can produce reproducible results, it has
some obvious disadvantages, such as incomplete genome coverage
(as it does not include Y chromosomes). SNP arrays with higher
density such as a 500K array may overcome this limitation. It is also
possible when an array with a much higher density of probes is
used, the copy number variation (CNV) along the genome may
further complicate the analysis. The optimized density of probes of
array for PGD aneuploidy detection needs to be further studied and
some analytic software must be improved.
Another disadvantage of this as a CGH system is the period
required for MDA and hybridization, which may not be a problem
for those facilities with an IVF laboratory and PGD laboratory, but
could limit the clinical application for transport PGD. One strategy
to overcome this problem is to cryopreserve the embryos after
biopsy, and transfer the embryos in a subsequent cycle, as has been
done with metaphase CGH (Wilton et al., 2003). The main drawback
is that the embryo implantation potential would be reduced by the
freezing and thawing procedure. An alternative approach is the inves-
tigation of the ﬁrst polar body, which will provide sufﬁcient time to
perform transport PGD using aCGH system, but the presence of
meiosis II or a paternally or post-zygotically derived error increases
the misdiagnosis risk signiﬁcantly. After all, further research on how
to shorten the time required for MDA and hybridization may
provide the best hope for resolving the problem.
In conclusion, the present study indicates that satisfactory genome
coverage can be obtained from single-cell MDA. The assessment of
the ﬁdelity of MDA for single cells or a small number of cells and the
comprehensive proﬁle using the SNP mapping array revealed a reason-
able accurate representation of MDA from a minute amount of DNA
template. Furthermore, a high concordance of copy number estimation
could be obtained when the MDA ampliﬁed product was used as refer-
ence. With a high-density SNP array, MDA products from single cells
can accurately and reliably be used for chromosome copy number
analysis and most likely for genotyping as well.
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